FDA — authorised 28 December 2012
- Application: NDA202155
- Marketing authorisation holder: BRISTOL MYERS SQUIBB
- Local brand name: ELIQUIS
- Indication: TABLET — ORAL
- Status: approved
🇺🇸 Apixaban Oral Tablet [Eliquis] in United States
FDA authorised Apixaban Oral Tablet [Eliquis] on 28 December 2012
Marketing authorisations
FDA — authorised 17 April 2025
- Application: NDA220073
- Marketing authorisation holder: BRISTOL
- Local brand name: ELIQUIS
- Indication: TABLET — ORAL
- Status: approved
Frequently asked questions
Is Apixaban Oral Tablet [Eliquis] approved in United States?
Yes. FDA authorised it on 28 December 2012; FDA authorised it on 17 April 2025.
Who is the marketing authorisation holder for Apixaban Oral Tablet [Eliquis] in United States?
BRISTOL MYERS SQUIBB holds the US marketing authorisation.